Stock Yearly Return 2016
Start date: 12/31/2015
End date: 12/30/2016
Start price/share: $2,662.00
End price/share: $1,100.00
Dividends collected/share: $0.00
Total return: -58.68%
Average Annual Total Return: -58.68%
Starting investment: $10,000.00
Ending investment: $4,132.00
Years: 1.00


ACHV average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare ACHV average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into ACHV


Also see:
ACHV stock yearly return 2017
ACHV stock yearly return 2018
ACHV stock yearly return 2019
ACHV stock yearly return 2020
ACHV YTD return
ACHV average annual return 10 years
Achieve Life Sciences is a pharmaceutical company engaged in the development and commercialization of cytisinicline for smoking cessation and nicotine addiction. Co.'s product candidate, cytisinicline, is a naturally occurring plant-based alkaloid from the seeds of the Laburnum anagyroides plant. Cytisinicline is structurally similar to nicotine and has a dual-acting mechanism of action that is both agonistic and antagonistic. Cytisinicline interacts with nicotine receptors in the brain by reducing the severity of nicotine withdrawal symptoms through agonistic binding to nicotine receptors and by reducing the reward and satisfaction associated with nicotine through antagonistic properties. The ACHV stock yearly return is shown above.

The yearly return on the ACHV stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2016 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the ACHV annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for ACHV:
ACHV SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Achieve Life Science (ACHV) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

ACOR Average Annual Return
ACRS Average Annual Return
ACRX Average Annual Return
ACST Average Annual Return
ADMA Average Annual Return
ADMP Average Annual Return
ADMS Average Annual Return
ADPT Average Annual Return
ADRO Average Annual Return
ADUS Average Annual Return
More Healthcare companies »

 

ACHV Stock Yearly Return 2016 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.